Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05348603 · ClinicalTrials.gov registry record · NA

Electronic Health Record Strategies to Promote Diverse Participation in Research

A NA study of Patient Participation, sponsored by Yale University.

Completed
Registry status
NA
Development phase
726,199
Enrollment target
1
Study location

NCT05348603 is a NA study of Patient Participation that has completed, run by Yale University. The registered enrollment target is 726,199 participants, above the 43,319-participant average among 5 other Patient Participation trials with a reported enrollment target (1576% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05348603, a NA study of Patient Participation, has completed, sponsored by Yale University.

COMPLETED
Registry status
NA
Development phase
726,199 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to determine the effectiveness of enhanced features in an online patient portal including banners, a chatbot, and direct to patient message and traditional mailed letters on increasing interest in research among online patient portal users.

Conditions Studied

Interventions

  • OTHER Chatbot
  • OTHER Traditional Letter
  • OTHER Direct to Patient Message
  • OTHER Banner

Study Locations (1)

Connecticut

  • Yale University - New Haven

Trial Details

FieldValue
Enrollment Target 726,199 participants
Start Date 2022-09-13
Est. Completion 2023-11-14
Phase NA

Sponsor

Yale University

1,492 total trials

What the Registry Record Tells You About NCT05348603

The ClinicalTrials.gov registry entry for NCT05348603 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 726,199 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 43,319-participant average among 5 other Patient Participation trials with a reported enrollment target (1576% higher). The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Patient Participation appearing as the primary indexed condition, and to 4 interventions - of which Chatbot is the first listed.

NCT05348603 reports 1 study location spanning 1 distinct geographic area - top geographies include Connecticut.

Frequently Asked Questions

What is clinical trial NCT05348603 about?

NCT05348603 is a clinical study titled "Electronic Health Record Strategies to Promote Diverse Participation in Research". The purpose of this study is to determine the effectiveness of enhanced features in an online patient portal including banners, a chatbot, and direct to patient message and traditional mailed letters on increasing interest in research among online patient portal users.

What is the current status of trial NCT05348603?

This trial is currently completed. It is a NA study. The enrollment target is 726,199 participants. The study started on 2022-09-13. Estimated completion is 2023-11-14.

What conditions does trial NCT05348603 study?

This clinical trial studies the following conditions: Patient Participation.

What interventions are being tested in trial NCT05348603?

The interventions under investigation include: Chatbot (OTHER), Traditional Letter (OTHER), Direct to Patient Message (OTHER), Banner (OTHER).

Who is sponsoring clinical trial NCT05348603?

This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05348603 being conducted?

This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Patient Participation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.